HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM was delisted on the 14th of June, 2023.
21 hedge funds and large institutions have $10M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 20 → 21 (+1)
37% less capital invested
Capital invested by funds: $16M → $10M (-$5.99M)
89% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$14K |
| 2 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
+$6.15K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$4.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$391K |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$181K |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
-$67.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$26K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$17.3K |
HTGM Hedge Fund Activity: Q1 2016 in Review
21 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q1 2016, worth a combined $10M — down 37% from $16M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new HTGM positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 9 trimmed.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $14K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $391K sold.
- 21 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q1 2016, up from 20 in Q4 2015.
- Funds reported $10M of HTG Molecular Diagnostics, Inc. Common Stock stock for Q1 2016, down 37% quarter-over-quarter.
- 3 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q1 2016 and 2 closed out, a net change of +1 holder.
- The largest HTG Molecular Diagnostics, Inc. Common Stock buyer in Q1 2016 was Deutsche Bank, an estimated $14K added.
- The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q1 2016 was Alyeska Investment Group, an estimated $391K sold.
Based on aggregated 13F filings for Q1 2016.